[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global RNAi for Therapeutic Market Growth (Status and Outlook) 2024-2030

January 2024 | 115 pages | ID: GBB592E8288EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global RNAi for Therapeutic market size was valued at US$ 172.2 million in 2023. With growing demand in downstream market, the RNAi for Therapeutic is forecast to a readjusted size of US$ 2288.1 million by 2030 with a CAGR of 44.7% during review period.

The research report highlights the growth potential of the global RNAi for Therapeutic market. RNAi for Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNAi for Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNAi for Therapeutic market.

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Global RNAi for Therapeutic key players include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc. Global top five manufacturers hold a share over 85%.

US is the largest market, with a share over 75%, followed by EU, which has a share about 3%.

In terms of product, siRNA is the largest segment, with a share over 55%. And in terms of application, the largest application is Cancer, followed by HBV, Cardiovascular, etc.

Key Features:

The report on RNAi for Therapeutic market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the RNAi for Therapeutic market. It may include historical data, market segmentation by Type (e.g., siRNA, miRNA), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNAi for Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the RNAi for Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the RNAi for Therapeutic industry. This include advancements in RNAi for Therapeutic technology, RNAi for Therapeutic new entrants, RNAi for Therapeutic new investment, and other innovations that are shaping the future of RNAi for Therapeutic.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNAi for Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for RNAi for Therapeutic product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNAi for Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNAi for Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNAi for Therapeutic market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNAi for Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNAi for Therapeutic market.

Market Segmentation:

RNAi for Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • siRNA
  • miRNA
  • shRNA
Segmentation by application
  • Cancer
  • Cardiovascular
  • HBV
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Alnylam Pharmaceuticals
  • Arbutus Biopharma (Tekmira)
  • Arrowhead
  • Dicerna Pharmaceuticals
  • Mirna Therapeutics
  • Quark Pharmaceuticals
  • RXi Pharmaceuticals
  • Silence Therapeutics
  • Benitec Biopharma
  • miRagen Therapeutics
  • Sylentis
  • Gradalis
  • Sirnaomics
  • Silenseed
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNAi for Therapeutic Market Size 2019-2030
  2.1.2 RNAi for Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNAi for Therapeutic Segment by Type
  2.2.1 siRNA
  2.2.2 miRNA
  2.2.3 shRNA
2.3 RNAi for Therapeutic Market Size by Type
  2.3.1 RNAi for Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
2.4 RNAi for Therapeutic Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular
  2.4.3 HBV
  2.4.4 Others
2.5 RNAi for Therapeutic Market Size by Application
  2.5.1 RNAi for Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global RNAi for Therapeutic Market Size Market Share by Application (2019-2024)

3 RNAI FOR THERAPEUTIC MARKET SIZE BY PLAYER

3.1 RNAi for Therapeutic Market Size Market Share by Players
  3.1.1 Global RNAi for Therapeutic Revenue by Players (2019-2024)
  3.1.2 Global RNAi for Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAI FOR THERAPEUTIC BY REGIONS

4.1 RNAi for Therapeutic Market Size by Regions (2019-2024)
4.2 Americas RNAi for Therapeutic Market Size Growth (2019-2024)
4.3 APAC RNAi for Therapeutic Market Size Growth (2019-2024)
4.4 Europe RNAi for Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa RNAi for Therapeutic Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas RNAi for Therapeutic Market Size by Country (2019-2024)
5.2 Americas RNAi for Therapeutic Market Size by Type (2019-2024)
5.3 Americas RNAi for Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNAi for Therapeutic Market Size by Region (2019-2024)
6.2 APAC RNAi for Therapeutic Market Size by Type (2019-2024)
6.3 APAC RNAi for Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNAi for Therapeutic by Country (2019-2024)
7.2 Europe RNAi for Therapeutic Market Size by Type (2019-2024)
7.3 Europe RNAi for Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNAi for Therapeutic by Region (2019-2024)
8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNAI FOR THERAPEUTIC MARKET FORECAST

10.1 Global RNAi for Therapeutic Forecast by Regions (2025-2030)
  10.1.1 Global RNAi for Therapeutic Forecast by Regions (2025-2030)
  10.1.2 Americas RNAi for Therapeutic Forecast
  10.1.3 APAC RNAi for Therapeutic Forecast
  10.1.4 Europe RNAi for Therapeutic Forecast
  10.1.5 Middle East & Africa RNAi for Therapeutic Forecast
10.2 Americas RNAi for Therapeutic Forecast by Country (2025-2030)
  10.2.1 United States RNAi for Therapeutic Market Forecast
  10.2.2 Canada RNAi for Therapeutic Market Forecast
  10.2.3 Mexico RNAi for Therapeutic Market Forecast
  10.2.4 Brazil RNAi for Therapeutic Market Forecast
10.3 APAC RNAi for Therapeutic Forecast by Region (2025-2030)
  10.3.1 China RNAi for Therapeutic Market Forecast
  10.3.2 Japan RNAi for Therapeutic Market Forecast
  10.3.3 Korea RNAi for Therapeutic Market Forecast
  10.3.4 Southeast Asia RNAi for Therapeutic Market Forecast
  10.3.5 India RNAi for Therapeutic Market Forecast
  10.3.6 Australia RNAi for Therapeutic Market Forecast
10.4 Europe RNAi for Therapeutic Forecast by Country (2025-2030)
  10.4.1 Germany RNAi for Therapeutic Market Forecast
  10.4.2 France RNAi for Therapeutic Market Forecast
  10.4.3 UK RNAi for Therapeutic Market Forecast
  10.4.4 Italy RNAi for Therapeutic Market Forecast
  10.4.5 Russia RNAi for Therapeutic Market Forecast
10.5 Middle East & Africa RNAi for Therapeutic Forecast by Region (2025-2030)
  10.5.1 Egypt RNAi for Therapeutic Market Forecast
  10.5.2 South Africa RNAi for Therapeutic Market Forecast
  10.5.3 Israel RNAi for Therapeutic Market Forecast
  10.5.4 Turkey RNAi for Therapeutic Market Forecast
  10.5.5 GCC Countries RNAi for Therapeutic Market Forecast
10.6 Global RNAi for Therapeutic Forecast by Type (2025-2030)
10.7 Global RNAi for Therapeutic Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Alnylam Pharmaceuticals Company Information
  11.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Product Offered
  11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Alnylam Pharmaceuticals Main Business Overview
  11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Arbutus Biopharma (Tekmira)
  11.2.1 Arbutus Biopharma (Tekmira) Company Information
  11.2.2 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offered
  11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Arbutus Biopharma (Tekmira) Main Business Overview
  11.2.5 Arbutus Biopharma (Tekmira) Latest Developments
11.3 Arrowhead
  11.3.1 Arrowhead Company Information
  11.3.2 Arrowhead RNAi for Therapeutic Product Offered
  11.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Arrowhead Main Business Overview
  11.3.5 Arrowhead Latest Developments
11.4 Dicerna Pharmaceuticals
  11.4.1 Dicerna Pharmaceuticals Company Information
  11.4.2 Dicerna Pharmaceuticals RNAi for Therapeutic Product Offered
  11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Dicerna Pharmaceuticals Main Business Overview
  11.4.5 Dicerna Pharmaceuticals Latest Developments
11.5 Mirna Therapeutics
  11.5.1 Mirna Therapeutics Company Information
  11.5.2 Mirna Therapeutics RNAi for Therapeutic Product Offered
  11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Mirna Therapeutics Main Business Overview
  11.5.5 Mirna Therapeutics Latest Developments
11.6 Quark Pharmaceuticals
  11.6.1 Quark Pharmaceuticals Company Information
  11.6.2 Quark Pharmaceuticals RNAi for Therapeutic Product Offered
  11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Quark Pharmaceuticals Main Business Overview
  11.6.5 Quark Pharmaceuticals Latest Developments
11.7 RXi Pharmaceuticals
  11.7.1 RXi Pharmaceuticals Company Information
  11.7.2 RXi Pharmaceuticals RNAi for Therapeutic Product Offered
  11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 RXi Pharmaceuticals Main Business Overview
  11.7.5 RXi Pharmaceuticals Latest Developments
11.8 Silence Therapeutics
  11.8.1 Silence Therapeutics Company Information
  11.8.2 Silence Therapeutics RNAi for Therapeutic Product Offered
  11.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Silence Therapeutics Main Business Overview
  11.8.5 Silence Therapeutics Latest Developments
11.9 Benitec Biopharma
  11.9.1 Benitec Biopharma Company Information
  11.9.2 Benitec Biopharma RNAi for Therapeutic Product Offered
  11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Benitec Biopharma Main Business Overview
  11.9.5 Benitec Biopharma Latest Developments
11.10 miRagen Therapeutics
  11.10.1 miRagen Therapeutics Company Information
  11.10.2 miRagen Therapeutics RNAi for Therapeutic Product Offered
  11.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 miRagen Therapeutics Main Business Overview
  11.10.5 miRagen Therapeutics Latest Developments
11.11 Sylentis
  11.11.1 Sylentis Company Information
  11.11.2 Sylentis RNAi for Therapeutic Product Offered
  11.11.3 Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Sylentis Main Business Overview
  11.11.5 Sylentis Latest Developments
11.12 Gradalis
  11.12.1 Gradalis Company Information
  11.12.2 Gradalis RNAi for Therapeutic Product Offered
  11.12.3 Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Gradalis Main Business Overview
  11.12.5 Gradalis Latest Developments
11.13 Sirnaomics
  11.13.1 Sirnaomics Company Information
  11.13.2 Sirnaomics RNAi for Therapeutic Product Offered
  11.13.3 Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Sirnaomics Main Business Overview
  11.13.5 Sirnaomics Latest Developments
11.14 Silenseed
  11.14.1 Silenseed Company Information
  11.14.2 Silenseed RNAi for Therapeutic Product Offered
  11.14.3 Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Silenseed Main Business Overview
  11.14.5 Silenseed Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. RNAi for Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of siRNA
Table 3. Major Players of miRNA
Table 4. Major Players of shRNA
Table 5. RNAi for Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global RNAi for Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. RNAi for Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global RNAi for Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global RNAi for Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global RNAi for Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. RNAi for Therapeutic Key Players Head office and Products Offered
Table 14. RNAi for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global RNAi for Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global RNAi for Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global RNAi for Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global RNAi for Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas RNAi for Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas RNAi for Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas RNAi for Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas RNAi for Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC RNAi for Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC RNAi for Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC RNAi for Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC RNAi for Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe RNAi for Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe RNAi for Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe RNAi for Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe RNAi for Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa RNAi for Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa RNAi for Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa RNAi for Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of RNAi for Therapeutic
Table 46. Key Market Challenges & Risks of RNAi for Therapeutic
Table 47. Key Industry Trends of RNAi for Therapeutic
Table 48. Global RNAi for Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global RNAi for Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global RNAi for Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global RNAi for Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Alnylam Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 53. Alnylam Pharmaceuticals RNAi for Therapeutic Product Offered
Table 54. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Alnylam Pharmaceuticals Main Business
Table 56. Alnylam Pharmaceuticals Latest Developments
Table 57. Arbutus Biopharma (Tekmira) Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 58. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offered
Table 59. Arbutus Biopharma (Tekmira) Main Business
Table 60. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Arbutus Biopharma (Tekmira) Latest Developments
Table 62. Arrowhead Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 63. Arrowhead RNAi for Therapeutic Product Offered
Table 64. Arrowhead Main Business
Table 65. Arrowhead RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Arrowhead Latest Developments
Table 67. Dicerna Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 68. Dicerna Pharmaceuticals RNAi for Therapeutic Product Offered
Table 69. Dicerna Pharmaceuticals Main Business
Table 70. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Dicerna Pharmaceuticals Latest Developments
Table 72. Mirna Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 73. Mirna Therapeutics RNAi for Therapeutic Product Offered
Table 74. Mirna Therapeutics Main Business
Table 75. Mirna Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Mirna Therapeutics Latest Developments
Table 77. Quark Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 78. Quark Pharmaceuticals RNAi for Therapeutic Product Offered
Table 79. Quark Pharmaceuticals Main Business
Table 80. Quark Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Quark Pharmaceuticals Latest Developments
Table 82. RXi Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 83. RXi Pharmaceuticals RNAi for Therapeutic Product Offered
Table 84. RXi Pharmaceuticals Main Business
Table 85. RXi Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. RXi Pharmaceuticals Latest Developments
Table 87. Silence Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 88. Silence Therapeutics RNAi for Therapeutic Product Offered
Table 89. Silence Therapeutics Main Business
Table 90. Silence Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Silence Therapeutics Latest Developments
Table 92. Benitec Biopharma Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 93. Benitec Biopharma RNAi for Therapeutic Product Offered
Table 94. Benitec Biopharma Main Business
Table 95. Benitec Biopharma RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Benitec Biopharma Latest Developments
Table 97. miRagen Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 98. miRagen Therapeutics RNAi for Therapeutic Product Offered
Table 99. miRagen Therapeutics Main Business
Table 100. miRagen Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. miRagen Therapeutics Latest Developments
Table 102. Sylentis Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 103. Sylentis RNAi for Therapeutic Product Offered
Table 104. Sylentis RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Sylentis Main Business
Table 106. Sylentis Latest Developments
Table 107. Gradalis Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 108. Gradalis RNAi for Therapeutic Product Offered
Table 109. Gradalis Main Business
Table 110. Gradalis RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Gradalis Latest Developments
Table 112. Sirnaomics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 113. Sirnaomics RNAi for Therapeutic Product Offered
Table 114. Sirnaomics Main Business
Table 115. Sirnaomics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Sirnaomics Latest Developments
Table 117. Silenseed Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors
Table 118. Silenseed RNAi for Therapeutic Product Offered
Table 119. Silenseed Main Business
Table 120. Silenseed RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Silenseed Latest Developments

LIST OF FIGURES

Figure 1. RNAi for Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi for Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. RNAi for Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. RNAi for Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. RNAi for Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global RNAi for Therapeutic Market Size Market Share by Type in 2023
Figure 10. RNAi for Therapeutic in Cancer
Figure 11. Global RNAi for Therapeutic Market: Cancer (2019-2024) & ($ Millions)
Figure 12. RNAi for Therapeutic in Cardiovascular
Figure 13. Global RNAi for Therapeutic Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 14. RNAi for Therapeutic in HBV
Figure 15. Global RNAi for Therapeutic Market: HBV (2019-2024) & ($ Millions)
Figure 16. RNAi for Therapeutic in Others
Figure 17. Global RNAi for Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 18. Global RNAi for Therapeutic Market Size Market Share by Application in 2023
Figure 19. Global RNAi for Therapeutic Revenue Market Share by Player in 2023
Figure 20. Global RNAi for Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 21. Americas RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure 22. APAC RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure 23. Europe RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure 25. Americas RNAi for Therapeutic Value Market Share by Country in 2023
Figure 26. United States RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC RNAi for Therapeutic Market Size Market Share by Region in 2023
Figure 31. APAC RNAi for Therapeutic Market Size Market Share by Type in 2023
Figure 32. APAC RNAi for Therapeutic Market Size Market Share by Application in 2023
Figure 33. China RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. India RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe RNAi for Therapeutic Market Size Market Share by Country in 2023
Figure 40. Europe RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Figure 41. Europe RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Figure 42. Germany RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. France RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2019-2024)
Figure 50. Egypt RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country RNAi for Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. APAC RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. Europe RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. United States RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Canada RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. Mexico RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Brazil RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. China RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Japan RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. Korea RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. India RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. Australia RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. Germany RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. France RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. UK RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. Italy RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Russia RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. Spain RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Egypt RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. South Africa RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. Israel RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. Turkey RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries RNAi for Therapeutic Market Size 2025-2030 ($ Millions)
Figure 80. Global RNAi for Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global RNAi for Therapeutic Market Size Market Share Forecast by Application (2025-2030)


More Publications